Associations - KDM6A mutation

BIOMARKER:

KDM6A mutation

Entrez ID:

Related biomarkers:

‹

›

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

KDM6A mutation KDM6A mutation	Gastric Cancer Gastric Cancer	5-fluorouracil Sensitive: B - Late Trials 5-fluorouracil Sensitive : B
KDM6A mutation KDM6A mutation	Acute Myelogenous Leukemia AML	cytarabine/daunorubicin liposomal formulation Resistant: C4 – Case Studies cytarabine/daunorubicin liposomal formulation Resistant : C4
KDM6A mutation KDM6A mutation	Renal Cell Carcinoma RCC	MRTX2219 Sensitive: D – Preclinical MRTX2219 Sensitive : D